ESR2 and colorectal carcinoma: Data obtained from the study of Honma demonstrated that ERβ gene cytosine-adenine (ESR2 CA) repeat polymorphism could be related to CRC risk through impairing ERβ signaling and lower wild-type ERβ expression [214].